.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Out-of-office blood-pressure monitoring can improve both diagnosis and ongoing treatment of hypertension by distinguishing sustained hypertension from white-coat and masked patterns. Home monitoring has the additional advantage of generating repeated measurements across several days, reducing the influence of a single clinic reading. For internists, structured home BP protocols can be especially valuable when adjusting medication, assessing resistant hypertension or investigating discordant office and ambulatory readings. Patients should use validated upper-arm devices with the correct cuff size and receive instruction on posture, rest period and repeated measurements. The data should be reviewed within a defined management plan, because monitoring without clinician response adds little value. Home BP also creates an opportunity to improve patient engagement by making treatment response visible. The practical message is straightforward: better measurement can prevent both overtreatment and undertreatment and can make hypertension care more data-driven without requiring expensive technology.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Out-of-office blood-pressure monitoring can improve both diagnosis and ongoing treatment of hypertension by distinguishing sustained hypertension from white-coat and masked patterns. Home monitoring has the additional advantage of generating repeated measurements across several days, reducing the influence of a single clinic reading. For internists, structured home BP protocols can be especially valuable when adjusting medication, assessing resistant hypertension or investigating discordant office and ambulatory readings. Patients should use validated upper-arm devices with the correct cuff size and receive instruction on posture, rest period and repeated measurements. The data should be reviewed within a defined management plan, because monitoring without clinician response adds little value. Home BP also creates an opportunity to improve patient engagement by making treatment response visible. The practical message is straightforward: better measurement can prevent both overtreatment and undertreatment and can make hypertension care more data-driven without requiring expensive technology.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
